Changes in the Characteristics of Kidney Cancer Detection During the COVID-19 Pandemic
Authors:
- László RumiLRLászló Rumi
- Árpád SzántóÁSÁrpád Szántó
- Dániel BányaiDBDániel Bányai
- Éva SzabóÉSÉva Szabó
- Antal ZemplényiAZAntal Zemplényi
- Szabolcs BellyeiSBSzabolcs Bellyei
- Emese MátyusEMEmese Mátyus
- Dóra HubaiDHDóra Hubai
- János GiránJGJános Girán
- István KissIstván Kiss
- Éva PozsgaiÉPÉva Pozsgai
- Árpád BoronkaiÁBÁrpád Boronkai
Open Access
Abstract
Background/objectives: The COVID-19 pandemic affected cancer care globally. Our objective was to analyze the demographic and clinical characteristics of kidney cancer (KC) patients between the pre-COVID-19 and COVID-19 periods. We also aimed to assess how KC was discovered—incidentally or symptomatically—and identify factors predicting the mode of discovery and advanced-stage disease. Methods: This retrospective study analyzed data from 400 patients aged 18 years or older diagnosed with kidney cancer (KC) at a large regional Hungarian clinical center during two time periods: the pre-COVID-19 period (1 January 2019 to 15 March 2020) and the COVID-19 period (16 March 2020 to 13 May 2021). Demographic and clinical information, including the mode of cancer discovery, was collected for all patients. Results: During the pandemic, monthly kidney cancer diagnoses declined by 10.3%. The proportion of female patients rose significantly from 31.9% to 42.9% (p = 0.023). Incidental tumor detection decreased from 82.4% to 72.4% (p = 0.018), while symptomatic presentation increased from 14.2% to 19.4%, although not significantly (p = 0.166). Non-incidental detection was associated with a 3.42-fold increase in odds of advanced cancer pre-pandemic and a 2.03-fold increase during the pandemic. Symptomatic presentation raised these odds by 4.51 and 2.76 times, respectively. Conclusions: Our study revealed changes in kidney cancer detection during the pandemic, including a rise in the proportion of female patients and a decline in case numbers, likely due to reduced incidental findings. Non-incidental discovery and symptom presence remained predictors of advanced-stage disease, although the odds were lower. Various factors—such as changes in healthcare access and gender-related differences in health-seeking behavior—may possibly explain these changes. Our findings support the critical role of incidental detection in high-risk populations.Keywords
Funding Information
- János Bolyai Research Scholarship of the Hungarian Academy of Sciences 2022
This publication has 53 references indexed in Scilit:
- The impact of the COVID-19 pandemic on renal cancer careWorld Journal of Urology, 2024
- Urological service provision during the COVID-19 period: the experience from an Irish tertiary centreIrish Journal of Medical Science (1971 -), 2021
- Uncertainty upon uncertainty: supportive Care for Cancer and COVID-19Supportive Care in Cancer, 2020
- Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and NutritionInternational Journal of Cancer, 2019
- Epidemiology and screening for renal cancerWorld Journal of Urology, 2018
- Smoking Status Is Not Sufficient to Accurately Target Patients Who Would Benefit from Screening for Bladder and Kidney CancerEuropean Urology Focus, 2015
- Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studiesInternational Journal of Cancer, 2004
- Gender differences in health: Are things really as simple as they seem?Social Science & Medicine, 1996
- Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian populationInternational Journal of Cancer, 1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987